
Rabeprazolevsesomeprazole in non-erosive gastro-esophageal reflux disease: A randomized, double-blind study in urban Asia
Author(s) -
KwongMing Fock,
EK Teo,
Tiing Leong Ang,
T S Chua,
Tony W. Ng,
Yl Tan
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i20.3091
Subject(s) - nerd , esomeprazole , rabeprazole , heartburn , gerd , medicine , proton pump inhibitor , gastroenterology , reflux , omeprazole , randomized controlled trial , adverse effect , disease
Gastro-esophageal reflux disease (GERD) is becoming increasingly common in Asia. Data on the efficacy of proton pump inhibitors in patients with non-erosive GERD (NERD) in Asia is lacking. This double-blind study compared the efficacy and safety of rabeprazole with esomeprazole in relief of symptoms in patients with NERD.